06978 永泰生物－Ｂ
按盘价 
2.850 +0.050 (+1.786%) | 日期 | 股东名称 | 披露原因 | 买入／卖出涉及 的股份数目 |
每股平均价 | 持有权益的 股份数目 |
占已发行 股本(%) |
| 04/08/2024 | 华润三九医药股份有限公司China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | 1711(L) | +165,595,721(L) | 165,595,721(L) | 32.18 | |
| 04/08/2024 | China Resources Company Limited | 1711(L) | +165,595,721(L) | 217,054,121(L) | 42.18 | |
| 04/08/2024 | China Resources Pharmaceutical Group Limited | 1711(L) | +165,595,721(L) | 217,054,121(L) | 42.18 | |
| 11/04/2023 | 郑铉哲 | 1304(S) | -90,128,571(S) | 44,820,000(L) | 8.71 | |
| 11/04/2023 | Evodevo LTD | 1304(S) | -90,128,571(S) | 44,820,000(L) | 8.71 | |
| 31/03/2023 | Tianjin Hongxun Technology Development Partnership (Limited Partnership)*(天津鸿勋科技发展合伙企业(有限合伙)) | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | |
| 31/03/2023 | 闫希军 | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | |
| 31/03/2023 | 闫凯境 | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | |
| 31/03/2023 | 李畇慧 | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | |
| 31/03/2023 | 吴乃峰 | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | |
| 31/03/2023 | Tianjin Zhongzhi Technology Development Co., Ltd.* (天津众智科技发展有限公司) | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | |
| 31/03/2023 | Tianjin Shanzhen Technology Development Partnership (Limited Partnership)*(天津善臻科技发展合伙企业(有限合伙)) | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | |
| 31/03/2023 | Tianjin Kangshun Technology Development Partnership (Limited Partnership)*(天津康顺科技发展合伙企业(有限合伙)) | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | |
| 31/03/2023 | Tianjin Fuhuade Technology Development Co., Ltd.*(天津富华德科技开发有限公司) | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | |
| 31/03/2023 | Tianjin Tasly Health Industry Investment Group Co., Ltd.*(天津天士力大健康产业投资集团有限公司) | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | |
| 31/03/2023 | Tasly Pharmaceutical Group Co.,Ltd.* (天士力医药集团股份有限公司) | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | |
| 31/03/2023 | Tianjin Dizhi Investment Management Co., Ltd.*(天津帝智投资管理有限公司) | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | |
| 31/03/2023 | Tianjin Tongming Technology Development Partnership (Limited Partnership)*(天津通明科技发展合伙企业(有限合伙)) | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | |
| 31/03/2023 | Tasly (Hong Kong) Pharmaceutical Investment Limited | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | |
| 31/03/2023 | Tianjin Shunqi Technology Development Partnership (Limited Partnership)*(天津顺祺科技发展合伙企业(有限合伙)) | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | |
| 31/03/2023 | Tianjin Heyue Technology Development Partnership (Limited Partnership)*(天津和悦科技发展合伙企业(有限合伙)) | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | |
| 31/03/2023 | Tasly Holding Group Co., Ltd.* (天士力控股集团有限公司) | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | |
| 20/02/2023 | Tianjin Fuhuade Technology Development Co., Ltd.*(天津富华德科技开发有限公司) | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | |
| 20/02/2023 | Tasly Pharmaceutical Group Co.,Ltd.* (天士力医药集团股份有限公司) | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | |
| 20/02/2023 | Tasly Holding Group Co., Ltd.* (天士力控股集团有限公司) | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | |
| 20/02/2023 | Tianjin Fuhuade Technology Development Co., Ltd.*(天津富华德科技开发有限公司) | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | |
| 20/02/2023 | Tianjin Zhongzhi Technology Development Co., Ltd.* (天津众智科技发展有限公司) | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | |
| 20/02/2023 | 李畇慧 | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | |
| 20/02/2023 | 吴乃峰 | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | |
| 20/02/2023 | 闫希军 | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | |
| 20/02/2023 | 谭月月 | 1316(L) | 6,714,286(L) | 59,794,286(L) | 11.62 | |
| 20/02/2023 | Tianjin Tongming Technology Development Partnership (Limited Partnership)*(天津通明科技发展合伙企业(有限合伙)) | 1205(L) | 191,595,721(L) | 37.23 | ||
| 20/02/2023 | Tianjin Shanzhen Technology Development Partnership (Limited Partnership)*(天津善臻科技发展合伙企业(有限合伙)) | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | |
| 20/02/2023 | Tianjin Shunqi Technology Development Partnership (Limited Partnership)*(天津顺祺科技发展合伙企业(有限合伙)) | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | |
| 20/02/2023 | Tianjin Kangshun Technology Development Partnership (Limited Partnership)*(天津康顺科技发展合伙企业(有限合伙)) | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | |
| 20/02/2023 | Tianjin Hongxun Technology Development Partnership (Limited Partnership)*(天津鸿勋科技发展合伙企业(有限合伙)) | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | |
| 20/02/2023 | Tianjin Heyue Technology Development Partnership (Limited Partnership)*(天津和悦科技发展合伙企业(有限合伙)) | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | |
| 20/02/2023 | 闫凯境 | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | |
| 20/02/2023 | Tasly (Hong Kong) Pharmaceutical Investment Limited | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | |
| 20/02/2023 | Tianjin Tasly Health Industry Investment Group Co., Ltd.*(天津天士力大健康产业投资集团有限公司) | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | |
| 1 2 | ||||||
| 备注： | (L) - 长仓：包括 (1) 持有股份；(2) 透过持有丶沽出或发行金融合约，有权或有责任购买相关股份。 |
| (S) - 短仓：包括 (1) 借入股份；(2) 透过持有丶沽出或发行金融合约，有权或有责任沽出相关股份。 | |
| (P) - 可供借出的股份 | |
| 即时报价更新时间为 04/09/2024 16:19 | |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |